TATIANA CURBELO: Open Payments
NPI 1487126660 · HIALEAH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 7 payments from 7 companies in 2025. Trend: 2023 $231 · 2024 $201 · 2025 $159
Food & beverage: $159
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 1 | $27 |
| Calliditas Therapeutics US Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| Travere Therapeutics, Inc. | 1 | $19 |
Products named: Auryxia, TARPEYO, FARXIGA, VOYXACT, Kerendia, Ozempic.
Industry payments across FL — which companies pay providers there.
